Cargando…
Pioneer factor Foxa2 enables ligand-dependent activation of type II nuclear receptors FXR and LXRα
OBJECTIVE: Type II nuclear hormone receptors, including farnesoid X receptors (FXR), liver X receptors (LXR), and peroxisome proliferator-activated receptors (PPAR), which serve as drug targets for metabolic diseases, are permanently positioned in the nucleus and thought to be bound to DNA regardles...
Autores principales: | Kain, Jessica, Wei, Xiaolong, Reddy, Nihal A., Price, Andrew J., Woods, Claire, Bochkis, Irina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350412/ https://www.ncbi.nlm.nih.gov/pubmed/34246806 http://dx.doi.org/10.1016/j.molmet.2021.101291 |
Ejemplares similares
-
OR33-06 Pioneer Factor Foxa2 Mediates Chromatin Conformation Changes In Ligand-dependent Activation Of FXR
por: Hao, Yi, et al.
Publicado: (2023) -
Changes at the nuclear lamina alter binding of pioneer factor Foxa2 in aged liver
por: Whitton, Holly, et al.
Publicado: (2018) -
Redistribution of lamina-associated domains reshapes binding of pioneer factor FOXA2 in development of nonalcoholic fatty liver disease
por: Wei, Xiaolong, et al.
Publicado: (2022) -
Berberine Promotes OATP1B1 Expression and Rosuvastatin Uptake by Inducing Nuclear Translocation of FXR and LXRα
por: Liu, Mingyi, et al.
Publicado: (2020) -
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
por: Seachrist, Darcie D., et al.
Publicado: (2021)